Faruqi & Faruqi, LLP Investigates Potential Claims Against Applied Therapeutics, Inc.

Summary

Faruqi & Faruqi, LLP is investigating potential claims against Applied Therapeutics, Inc. (NASDAQ: APLT) on behalf of investors who suffered losses between January 3, 2024, and December 2, 2024. The company allegedly made misleading statements about its Phase III INSPIRE trial, leading to inflated stock prices. Following an FDA complete response letter regarding its new drug application for govorestat, the stock price significantly declined. Investors are encouraged to contact the firm before the lead plaintiff application deadline on February 18, 2025.Benzinga

Impact Analysis

This event is classified as a company-level event since it specifically involves Applied Therapeutics, Inc. The investigation by Faruqi & Faruqi, LLP could lead to significant financial and reputational impacts on the company. The primary first-order effect is the direct negative impact on APLT’s stock price due to allegations of misleading statements and the subsequent FDA response, which may have prompted the stock’s decline. Second-order effects may include increased scrutiny from regulators and a potential class-action lawsuit, which could further strain the company’s resources and investor confidence. For investors, this presents both risks and opportunities. The risks involve potential legal liabilities for Applied Therapeutics, which could decrease stock value further. However, there could be investment opportunities if the stock is oversold due to panic, assuming the company can resolve these issues successfully. Investors should monitor legal proceedings and FDA communications for further developments.Benzinga